Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2023.155041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Syam Mohan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia; School of Health Sciences, University of Petroleum and E…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Autoimmune Diseases, MicroRNAs, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 170 Literaturangaben.
Abstract (Originalsprache)
Autoimmune disorders represent a heterogeneous spectrum of conditions defined by an immune system's atypical reactivity against endogenous constituents. In the complex anatomy of autoimmune pathogenesis, lncRNAs have appeared as pivotal arbiters orchestrating the mechanisms of ailment initiation, immune cascades, and transcriptional modulation. One such lncRNA, MALAT1, has garnered attention for its potential association with the aetiology of several autoimmune diseases. MALAT1 has been shown to influence a wide spectrum of cellular processes, which include cell multiplication and specialization, as well as apoptosis and inflammation. In autoimmune diseases, MALAT1 exhibits both disease-specific and shared patterns of dysregulation, often correlating with disease severity. The molecular mechanisms underlying MALAT1's impact on autoimmune disorders include epigenetic modifications, alternative splicing, and modulation of gene expression networks. Additionally, MALAT1's intricate interactions with microRNAs, other lncRNAs, and protein-coding genes further underscore its role in immune regulation and autoimmune disease progression. Understanding the contribution of MALAT1 in autoimmune pathogenesis across different diseases could offer valuable insights into shared pathways, thereby clearing a path for the creation of innovative and enhanced therapeutic approaches to address these complex disorders. This review aims to elucidate the complex role of MALAT1 in autoimmune disorders, encompassing rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), type 1 diabetes, systemic lupus erythematosus, and psoriasis. Furthermore, it discusses the potential of MALAT1 as a diagnostic biomarker, therapeutic target, and prognostic indicator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia; School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India; Center for Global health…
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al-Quwayiyah, Shaqra University, Riyadh, Saudi Arabia. Electronic address: m.hakami@su.edu.sa.
- Research and Scientific Studies Unit, College of Nursing, Jazan University, Jazan 45142, Saudi Arabia.
- Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Zitieren
APA
Mohan, S., Hakami, M. A., Dailah, H. G., Khalid, A., Najmi, A., Zoghebi, K., & Halawi, M. A. (2024). Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.155041
Vancouver
Mohan S, Hakami MA, Dailah HG, Khalid A, Najmi A, Zoghebi K, et al. Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2023.155041
BibTeX
@article{Mohan2024,
author = {Mohan, Syam and Hakami, Mohammed Ageeli and Dailah, Hamad Ghaleb and Khalid, Asaad and Najmi, Asim and Zoghebi, Khalid and Halawi, Maryam A},
title = {Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2023.155041}
}
EUVIMED